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We have previously reported data from clinical and 
laboratory animal observations which suggest that 
organ tolerance after transplantation depends on a 
state of balanced Iymphodendritic cell chimerism 
between the host and donor graft. We have sought 
further evidence to support this hypothesis by 
investigating HLA-mismatched liver allograft 
recipients. 
9 of 9 female recipients of livers from male donors 
had chimerism in their allografts and extrahepatic 
tissues, according to in-situ hybridisation and 
molecular techniques 10 to 19 years post-
transplantation. In 8 women with good graft 
function, evidence of the Y chromosome was found 
in the blood (6/8), skin (8/8), and lymph nodes 
(7/8). A ninth patient whose transplant failed after 
12 years from recurrent chronic viral hepatitis had 
chimerism in her lymph nodes, skin, jejunum, and 
aorta at the time of retransplantation. 
Although cell migration is thought to take place 
after all types oftransplantation, the large population 
of migratory cells in, and the extent of their seeding 
from, hepatic grafts may explain the privileged 
tolerogenicity of the liver compared with other 
organs. 
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The hypothesis that acceptance of whole organ allografts 
depends on the exchange of a special leucocyte population 
between the donor organ and recipient with subsequent 
chimerism in both' was tested in 9 women who received 
livers from ABO identical but HLA mismatched male 
donors. Prednisone doses were 0-15 mg/day and 
maintenance baseline immunosuppression was with 
azathioprine in 5 patients, cyclosporin in 3, and nothing in a 
non-compliant ninth patient whose hepatic graft was failing 
12 years after transplantation and 7 years after stopping 
cyclosporin. 
Tissue collection in the 8 patients under continuous 
immunosuppression consisted of a needle biopsy of the liver, a small 
piece of skin excised from the groin, and an inguinal lymph node; 
blood samples were also taken. To avoid genetic contamination, the 
biopsy of the liver allograft was completed in a separate room with 
different instruments than used for the skin and lymph-node 
biopsies. The patient who had stopped cyclosporin was the only one 
whose liver function was abnonnal. However, the allograft removed 
at her hepatic retransplantation in April, 1992, was found to have 
been destroyed by recurrent hepatitis C virus rather than by 
rejection. At this operation, multiple tissue specimens were 
obtained, including portions of jejunum from the roux-en-Y biliary 
reconstruction and an ellipse of her aorta removed for a Carrell 
patch arterial reconstruction. 
Fluorescent in-situ hybridisation in the formalin-fIxed female 
recipient tissues was done with cloned, biotinylated DNA probes 
directed against satellite DNA sequences specifIc for the Y 
I chromosome (Oncor, Gaithersburg, Maryland, USA). Tissues 
of known sex served as controls. In addition, the male allograft 
liver was taken as a fixation and digestion control in each run. 
Tissues were examined and photographed using ASA 80011600 
colour reversal film on a Nikon Optiphot II epifluorescence 
microscope. 
For polymerase chain reaction (PCR) studies, oligonucleotides 
specific for the satellite region of the Y chromosome centromere 
Y_A2 and for the sex-detennining region of the Y chromosome3 
were used as primers to determine the presence of male DNA in the 
female recipient tissues. After Southern blotting, the amplified 
material was hybridised to radioactively labelled Y -specific probes 
to confirm the specificity of the bands visualised in an agarase gel 
after ethidium bromide staining. As with in-situ hybridisation, the 
allograft liver samples were invariably strongly positive for the Y 
probes. 
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MICROCHIMERISM ACCORDING TO Y CHROMOSOME 
DETECTION WITH IN-SITU HYBRIDISATION OR PCR 
Tissue distribution 
Liver allograft Blood lymph node Skin 
. -
-
Date of In-situ In-situ In-situ 
(age at) hybrid- hybrid- hybrid-
transplant* isation PCR PCR isation PCR isation PCR 
1. 21/1/76 (30) +++ +++ + + - + + 
2. 26/2/78 (5) +++ +++ + + + + NT 
3. 9/3/80 (29) NT +++ - NT - NT + 
4. 4/1/78 (2) +++ +++ + + + + NT 
5, 21/3/SO (34) +++ +++ + - - + + 
6, 18/2/73 (3) +++ +++ - - + + + 
7,28/2/82 (45) +++ +++ + + + + + 
8. 9/9/79 (35) +++ +++ + + + + + 
9, 29/8/sot (28 +++ +++ NT + - - + 
-All postoperative studies completed in April-June. 1992. 
tThis patient also tested positive in intestine with in-situ hybridisation and peR, and 
in the aorta with peR. 
Hepatocytes, bileduct epithelium, and endothelium of 
allografts stained positive for hybridisation (table); this 
result was expected because these cells are known to reta.in 
donor specificity,4 The signal varied from case to case and 
between different cell types, Under oil immersion, the probe 
produced a linear-reticular fluorescence characteristic of the 
Y chromosome at the edge of the nucleus in about 60% of 
hepatocytes, However, round-shaped signals were not 
uncommon, In each case, it was important to compare the 
signal in the liver with the cells detected in recipient tissues, 
To identify donor cells in the skin often required extensive 
searching; they were frequently located in stromal tissue 
near epithelial cells of the epidermis, hair follicles, or adnexal 
structures, in the peri-adventitial sheath of arteries, or 
around small superficial dermal blood vessels, Positive cells 
in lymph nodes were detected in the capsule adjacent to 
blood vessels and in lymphoid stroma, 
All 9 recipients were chimeras according to peR, and 
usually in more than one site (figure), Amongst well 
patients, blood chimerism was found in 6 of 8, skin 
chimerism in all 6 tested, and lymph-node chimerism in 5 of 
BL LN SK c 
PCR demonstration of chimerism in blood. lymph nodes. and 
skin of patient 8, 
Genomic DNA obtained after a Y -specific amplification of liver, 
blood (Bl).lymph node (IN). and skin (SK) was run on an agarase gel 
and then Southern blotted to a nylon membrane. DNA from the blood 
of an unrelated female ('2) and an unrelated male (J) was also amplified 
and added as negative and positive contra Is. The control for PCR 
amplification (C) was added in the sixth lane of the gel. The liver 
specimen was not included in the gel because the signal generated 
from liver DNA, blotted in the same quantity as the other samples, was 
so intense that it would cover the other specific bands, To test the 
sensitivity of OLir procedure, the positive control contained male DNA 
diluted into female DNA at a ratio of 1 in 10000. 
8 (table), In the ninth patient, who lost her graft after 12 
years because of recurrent viral hepatitis, donor DNA was 
found in the skin, lymph nodes, jejunum, and aorta sampled 
at the time of retransplantation (table). At this time, she had 
not taken cyclosporin for 7 years . 
Peripheral blood lymphocytes from 4 of9 patients in this 
study were tested for in-vitro proliferative responses to 
mitogens (concanavalin A and phytohaemagglutinin) and 
with third-party mixed lymphocyte culture (MLR). All 
samples had proliferative responses in the normal range, 
Although donor cells were not available for MLR testing, 
many or most of these long survivors undoubtedly have 
stable donor-specific non-reactivity (tolerance) that is no 
longer drug dependent. Of 43 liver recipients whom we have 
followed for 101 to 22% years, 7 discontinued 
immunosuppression 6 to 18 years ago without subsequent 
rejection,s The ultimate step of drug weaning is being 
contemplated in other patients still receiving 
immunosuppressive therapy. 
The chimerism that has been found invariably in all 
long-surviving liver recipientsS seems to involve the 
movement of self-renewing cells from tissues to blood and 
vice versa. Donor DNA was found frequently in the blood of 
late-surviving patients in our study. Donor DNA 26 months 
after transplantation in the sternum of a recently reported 
liver recipient whose diagnosis was Gaucher's disease has 
shown that the bone marrow can be one of the intermediary 
sites in cell movement.6 
Although we believe that similar chimerism is the basis 
for the acceptance of all whole-organ transplants,1.7 the 
disproportionately heavy endowment of hepatic grafts with 
potentially migratory dendritic cells, macrophages, and 
other leucocytes of bone marrow origin may help explain 
why the liver is more tolerogenic than other organs,8.9 
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